ENO2 and brain neoplasm: Serum neuronal biomarkers, such as neuron-specific enolase (NSE) [1], S100β [2], and glial fibrillary acidic protein (GFAP) [3, 4], have been reported to be upregulated in patients with brain tumors caused by brain injuries.